Dr Jinah Yoo

MBCHB FRCP(DERM) PG DIP MSC MSC

Dr Jinah Yoo is a Korean UK-trained consultant dermatologist who is the founder and medical director of Dr Jinah Yoo Dermatology.


Dr Yoo has completed intensive dermatology training and developed special interest in cosmetic dermatology, hyperpigmentary disorders and skin lymphoma. She has completed two Master’s degrees in addition to her medical training and has been awarded Distinction in MSc (Skin Ageing and Aesthetic Medicine) at the University of Manchester. Spending the final year of her MSc doing her projects on facial hyperpigmentation equipped her with scientific knowledge on aetiology and evidence-based approach in the management of hyperpigmentation.

She attended numerous observerships at the World’s leading pigment/cosmetic dermatology clinics in USA, Singapore and South Korea and established the first NHS-based hyperpigmentation service at Queen Elizabeth Hospital in 2018.

She has been elected to Royal College of Physician fellowship (FRCP) for her ongoing contribution to the advances in dermatology specialty. She is actively involved in education and research and her works are regularly presented at national/international conferences and published in peer-review journals.

Dr Jinah Yoo | Dr Jinah Yoo X Maylin

  • Current Roles

    • Founder and Medical Director at Maylin x Dr Jinah Yoo Dermatology
    • Key Opinion Leader of Lutronic
    • Key Opinion Leader of Viol
    • Key Opinion Leader of Revitacare
    • International Advisory Board Member, DEMIRE (Korean Aesthetic Surgery and Laser Society)
    • Honorary Senior Clinical Lecturer at University of Birmingham
    • Honorary Lecturer at University of Manchester

  • Previous Roles

    • Founder and Medical Director at Dr Jinah Yoo Dermatology, London
    • Research Supervisor for Dermatology Registrars at Queen Elizabeth Hospital Birmingham
    • Alumni Tutor for MSc Skin Ageing and Aesthetic Medicine, University of Manchester
    • Honorary Consultant President of University of Birmingham DermSoc
    • Specialist Advisory Board, Complications in Medical Aesthetics Collaborative (CMAC)
    • Consultant Dermatologist at Queen Elizabeth Hospital Birmingham
    • Medical Director at Sk:n clinic (Bull Street and Harborne Road Branch in Birmingham)
    • Completion of Dermatology Registrar training in West Midlands
    • Completion of MSc in Immunology and Immuogenetics at University of Manchester
    • Completion of MSc in Skin Ageing and Aesthetic Medicine (Distinction) at University of Manchester
    • Completion of Postgraduate Diploma at Queen Mary University, London
    • Completion of Undergraduate Study at Birmingham Medical School

  • Qualifications

    • MBChB (University of Birmingham)
    • FRCP (UK)
    • PG Diploma (clinical dermatology, Queen Mary University)
    • MSc (Immunology and immunogenetics, University of Manchester)
    • MSc Distinction (Skin ageing and aesthetic medicine, University of Manchester)

  • Membership

    • British Association of Dermatologists
    • European Academy of Dermatology and Venerology
    • Korean Aesthetic Surgery & Laser Society

Publications & Presentations

Publications
  • Balogun M, Mathe N, Yoo J. Correspondence on prevailing dermatology-related topics on the rapidly growing TikTok social media platform. Clin Exp Dermatol. 2021 doi.org/10.1111/ced.14927
  • Yoo J. Differential diagnosis and management of hyperpigmentation. Clin Exp Dermatol. 2021 doi.org/10.1111/ced.14747
  • Odedra S, Yoo J. The risk of chemical leukoderma with skin lightening therapies. Clin Exp Dermatol Accepted May 2021
  • Jaulim SZ, Yoo J. Does high energy visible light emitted from electronic devices cause melasma? Clin Exp Dermatol 2021 doi.10.1111/ced.14573. Online ahead of print.
  • Mathe N, Balogun A, Yoo J. A case report on the use of topical cysteamine 5% cream in the management of refractory post-inflammatory hyperpigmentation resistant to triple combination cream (hydroquinone, topical corticosteroids and retinoids). J Cosm Dermatol. 2020;00:1–3. https://doi.org/10.1111/ jocd.13755
  • Ma Y, Millette D, Nalluri R, Yoo J. UK-based dermatologist online survey on the current practice and training in the management of melasma and postinflammatory hyperpigmentation. Clin Exp Dermatol. 2020. doi: 10.1111/ced.1419
  • Yoo J et al. Lymph node imaging and correlation with histological N-Class: Results from the PROCLIPI study show sum of the product of dimensions is the better predictor than single axis measurements. Eur J Cancer. 2019;119(1):S25.
  • Yoo J, Shah F, Velangi S, Stewart G, Hague J, Scarisbrick JJ. Three cases of new diagnosis of mycosis fungoides following commencement on biologic therapies for presumed psoriasis/eczema. Eur J Cancer. 2019;119(1):S41.
  • Ritchie S et al. Evaluation of haematopoietic stem cell transplantation in patients diagnosed with cutaneous T-cell lymphoma at a tertiary care centre: should we avoid chemotherapy in conditioning regimes? Br J Dermatol. 2019. doi: 10.1111/bjd.18541. [Epub ahead of print]
  • Wernham A, Fremlin G, Yoo J. Thinking outside the box: a challenging case of mucormycosis presenting as a necrotic cutaneous nasal plaque. Br J Dermatol. 2019;181(S1):129
  • Rai S, Millette D, Leong A. Verma M, Sawafta Z and Yoo J. Understanding the prevalence and current practice in the management of melasma in the UK-based dermatology clinic. Br J Dermatol. 2019;181(S1):87-88.
  • Molloy K, et al. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. Br J Dermato.l 2019 doi: 10.1111/bjd.18089.
  • Yoo J, Murray D, Shah F, Stevens A, Chaganti S, Scarisbrick JJ. Identification of predictive markers for stage progression in primary cutaneous anaplastic large cell lymphoma. Eur J Cancer. 2018;101(1):S8
  • Molloy K et al. Quality of life in patients with mycosis fungoides and Sezary syndrome is significantly worse in female patients, Sézary syndrome and those with more extensive skin involvement. Eur J Cancer. 2018; 101(1):S39
  • Peng C, Molloy K, Shah F, Drayson M, Scarisbrick JJ, Yoo J. The impact of skin infection on quality of life in patients with mycosis fungoides and Sezary syndrome. Eur J Cancer. 2018;101(1):S38
  • Ganatra B et al. The use of PET-CT in detecting histologically confirmed lymphomatous nodes in cutaneous T-cell lymphoma (CTCL): A cohort study from a Tertiary Skin Lymphoma Service. Eur J Cancer. 2018;101(1):S27
  • Scarisbrick JJ, et al. The PROCLIPI international registry of early stage Mycosis Fungoides identifies substantial diagnostic delay in most patients. Br J Dermatol 2018 Sept 29. doi: 10.1111/bjd.17258
  • Yoo J, Shah F, Velangi S, Stewart G, Scarisbrick JJ. Secukinumab for treatment of psoriasis: Does secukinumab precipitate or promote the presentation of cutaneous T cell lymphoma?. Clin Exp Dermatol. 2018 Oct 4. doi: 10.1111/ced.13777
  • Yu C, Fitzpatrick A, Cong D, Yao C, Yoo J, Turnbull A et al. Nitric oxide induces human CLA+CD25+Foxp3+regulatory T cells with skin-homing potential. J Allergy Clin Immunol 2017;140(5):1441-1444.
  • Yoo J, Shah F, Hodson J, Stevens A, Wong G, Cobbold M et al. Assessment of peripheral blood tumour burden in mycosis fungoides and Sézary Syndrome Shows Infrequent Involvement in Early and Tumour Stage Disease. J Immunol Serum Biol. 2015;1(1): 1- 7.
  • Scott-Lang V, Sinclair C, Yoo J et al. Enterovirus infection mimicking eczema herpeticum: a new entity? Br J Dermatol. 2014; 171(Suppl.1):118.
  • Mowbray M, Yoo J. Diagnostic biopsy of melanoma: primary or secondary care?. Br J GP. 2014;64(618):14
  • Al-Shammary N, Awan S, Butt K, Yoo J. Internet use before consultation with a health professional. Primary Health Care. 2007 Dec;17(10):18-21.
Presentations

International

  • Yoo J et al. Review of the measurements of abnormal lymph nodes on imaging and the correlation with N class from the PROspective Cutaneous Lymphoma International Prognostic Index study. World Congress of Cutaneous Lymphoma (WCCL) conference. Barcelona, Spain 12-14.02.2020 (oral)
  • Yoo J, Shah F, Velangi S, Stewart G, Hague J, Scarisbrick JJ. Three cases of new diagnosis of mycosis fungoides following commencement on biologic therapies for presumed psoriasis/eczema. European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force annual meeting. Athens, Greece 26-28.09.2019 (oral)
  • Yoo J et al. Lymph node imaging and correlation with histological N-Class: Results from the PROCLIPI study show sum of the product of dimensions is the better predictor than single axis measurements. EORTC Cutaneous Lymphoma Task Force annual meeting. Athens, Greece 26-28.09.2019 (oral)
  • Yoo J, Shah F, Velangi S, Stewart G, Hague J, Scarisbrick J. Three cases of new diagnosis of mycosis fungoides following commencement on biologic therapies for presumed psoriasis/eczema. EORTC Cutaneous Lymphoma Task Force annual meeting. Athens, Greece 26-28.09.2019 (oral)
  • Yoo J, Noyvert B, Beggs A, Moss P, Scarisbrick J. Identification of identical long copy number variations in matched blood and skin in Mycosis Fungoides and Sezary Syndrome using SNP arrays. World Congress of Dermatology (WCD). Milan, Italy 10-15.06.2019 (oral)
  • Yoo J, Millett D, Mathe N, National U.K dermatologists online survey on the training and management of skin hyperpigmentation. WCD. Milan, Italy 10-15.06.2019 (poster)
  • Millette D, Leong A, Verma M, Sawafta Z, Yoo J. Review of current practice to assess the addition of oral tranexamic acid to the melasma treatment ladder. WCD. Milan, Italy 10-15.06.2019 (poster)
  • Leong A, Sawafta Z, Verma M, Millett D, Yoo J. Prevalence and demographics of patients with hyperpigmentary disorders in dermatology outpatient setting in West Midlands, United Kingdom. WCD. Milan, Italy 10-15.06.2019 (poster)
  • Leong A, Verma M, Rai S, Sawafta Z, Millette D, Yoo J. Melasma and Post-inflammatory Hyperpigmentation: the Prevalence and Causes of Hyperpigmentation in a Dermatology Outpatient Clinic, United Kingdom. Skin of Color conference. Washington D.C, USA 28.02.2019 (poster)
  • Yoo J, Murray D, Shah F, Stevens A, Chaganti S, Scarisbrick J. Identification of predictive markers for stage progression in primary cutaneous anaplastic large cell lymphoma. EORTC Cutaneous Lymphoma Task Force annual meeting. St. Gallen, Switzerland 17.09-10.09.2018 (oral)
  • Molloy K et al. Quality of life in patients with mycosis fungoides and Sezary syndrome is significantly worse in female patients, Sézary syndrome and those with more extensive skin involvement. EORTC Cutaneous Lymphoma Task Force annual meeting. St. Gallen, Switzerland 17.09-10.09.2018 (oral)
  • Peng C, Molloy K, Shah F, Drayson M, Scarisbrick J, Yoo J. The impact of skin infection on quality of life in patients with mycosis fungoides and Sezary syndrome. EORTC Cutaneous Lymphoma Task Force annual meeting. St. Gallen, Switzerland 17.09-10.09.2018 (oral)
  • Ganatra B et al. The use of PET-CT in detecting histologically confirmed lymphomatous nodes in cutaneous T-cell lymphoma (CTCL): A cohort study from a Tertiary Skin Lymphoma Service. EORTC Cutaneous Lymphoma Task Force annual meeting. St. Gallen, Switzerland 17.09-10.09.2018 (poster)
  • Yoo J, Morfouce M, Hartmann K, Cazier JB, Noyvert B, Beggs A, Shah F, Moss P, Scarisbrick JJ. Successful identification of copy number variations using next generation sequencing with a tumour panel in plaque/tumour mycosis fungoides. International Society for Cutaneous Lymphomas Annual Meeting. Orlando, USA 16.05-19.05.2018 (oral)
  • Yoo J, Morfouce M, Hartmann K, Cazier JB, Noyvert B, Beggs A, Vermeer M, Shah F, Moss P, Scarisbrick JJ. Next generation sequencing using a tumour panel in macrodissected tumour cells from plaque/tumour mycosis fungoides in treatment naïve patients. EORTC Cutaneous Lymphoma Task Force annual meeting. London, U.K 13.10-15.10.2017 (oral)
  • Yoo J, Beggs A, Noyvert B, Murray D, Cazier J-B, Stockton J, Shah F, Stevens A, Chaganti S, Moss P and Scarisbrick J. Whole exome sequencing in mycosis fungoides. 26th European Academy of Dermatology and Venereology (EADV) Congress. Geneva, Switzerland 28.9 – 1.10.2017 (oral)
  • Yoo J, Beggs A, Noyvert B, Murray D, Cazier JB, Stockton J, Shah F, Stevens A, Chaganti S, Moss P and Scarisbrick J. Genomic landscape of mycosis fungoides. 3rd WCCL. New York, USA 26-28.10.2016 (oral)
  • Yoo J, Shah F, Lewis H, Martin-Clavijo A, Stevens A, Chaganti S and Scarisbrick J. Skin infection in mycosis fungoides and Sezary syndrome. 3rd WCCL. New York, USA 26-28.10.2016 (poster)
  • Murray DJ, Yoo J, Eldershaw S, Pearce H, Moss PAH and Scarisbrick J. Primary cutaneous large cell anaplastic lymphoma: the role of brentuximab when the outlook is poor. 3rd WCCL. New York, USA 26-28.10.2016 (poster)
  • Murray DJ, Yoo J, Eldershaw S, Pearce H, Moss PAH and Scarisbrick J. Dissecting the immune landscape of mycosis fungoides. 3rd WCCL. New York, USA 26-28.10.2016 (poster)
  • Yoo J, Stewart G. Scarring and milia formation following tinea faciei. 25th EADV Congress. Vienna, Austria 28.9 – 1.10.2016 (poster)
  • Yoo J, Madhogaria S. Anti-MDA5 antibody positive clinically amyopathic dermatomyositis with limited cutaneous disease, hoarseness and rapidly progressive interstitial lung disease. 25th EADV Congress. Vienna, Austria 28.9 – 1.10.2016 (poster)
  • Yoo J, Stewart G. Pseudorheumatoid nodule localised to the right elbow. 25th EADV Congress. Vienna, Austria 28.9 – 1.10.2016 (poster)
  • Yoo J, Verpetinske I. Psoriasis localised to right palm following right sided mastectomy. 25th EADV Congress. Vienna, Austria 28.9 – 1.10.2016 (poster)
  • Yoo J, Hejmadi R and Martin-Clavijo A. Collision tumour composed of basal cell carcinoma and cutaneous metastases from breast carcinoma. 24th EADV Congress. Copenhagen, Denmark 7-11.10.2015 (poster)
  • Yoo J, Shah F, Hodson J, Stevens A, Wong G, Cobbold M, Bryon J, Chaganti S, Clark F, Drayson M and Scarisbrick J. Analysis of Peripheral Blood Tumour Burden in Mycosis Fungoides and Sézary Syndrome. World Congress of Dermatology. Vancouvre, Canada 8-13.6.2015 (oral)
  • Yoo J, Shah F, Hodson J, Stevens A, Wong G, Cobbold M, Bryon J, Chaganti S, Clark F, Drayson M and Scarisbrick J. Measuring Peripheral Blood Tumour Burden in Mycosis Fungoides and Sézary Syndrome. EORTC Cutaneous Lymphoma Task Force annual meeting. Paris, France 24-26.10.2014 (poster)

National

  • Ma Y, Mathe N, Balogun A, Yoo J. Cysteamine 5% cream in skin hyperpigmentary disorders: a retrospective review. British Association of Dermatologists (BAD) annual meeting. Manchester. Sept 2020 (poster)
  • Rai S, Millette D, Leong A. Verma M, Sawafta Z, Yoo J. Understanding the prevalence and current practice in the management of melasma in the UK-based dermatology clinic. British Association of Dermatologists (BAD) annual meeting. Liverpool. July 2019 (oral)
  • Wernham A, Fremlin G, Yoo J. Thinking outside the box: a challenging case of mucormycosis presenting as a necrotic cutaneous nasal plaque. BAD annual meeting. Liverpool. July 2019 (oral)
  • Ismail D, Madhwapathi V, Yoo J, Madhogaria S, Ogboli M, Stewart DG. Paediatric generalised pustular psoriasis. BAD annual meeting. Birmingham, July 2016 (poster)
  • Scott-Lang V, Sinclair C, Yoo J, Nwafor N, Harvala H, Dylan B and Olivia S. Enterovirus infection mimicking eczema herpeticum: a new entity?. BAD annual meeting. Glasgow 2.7.2014 (oral)
  • Yoo J. Childhood atopic eczema: the demographics and management. British Society of Paediatric Dermatology Annual Symposium. Leeds, November 2009 (poster)
Prizes/Awards/Grants
  • World Congress of Dermatology Rising Star Scholarship (2019)
  • Midland Dermatological Society Travel Award (2017)
  • Sankey research poster prize winner (2017)
  • Eli Lily Healthcare provider restrictive grant (2016)
  • The British Skin Foundation small grant (2016)
  • World Congress of Dermatology scholarship (2015)